TENX - Catalyst 03/06/2024 - Possible gap fill

2 thg 3

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction.

This is not a financial advice!

Upcoming catalysts 03/06/2024

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Keep an eye on 5.6 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 4.3

TPs approx. 8.3 (gap fill)

Most info on the chart.

Trade carefully!

5 thg 3

Đóng lệnh: dừng lỗ